Neutrophil extracellular trap as a predictive marker to cisplatin-based chemotherapy for patients with muscle-invasive bladder cancer

被引：0
|
作者：
Shang, Bing-Qing
Gu, Zhaoru
Qu, Wang
Xie, Rui-Yang
Wu, Jie
Zhou, Ai-Ping
Shou, Jianzhong
机构：
[1] Chinese Acad Med Sci & Peking Union, Dept Urol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Etiol & Carcinogenesis, Natl Canc Ctr,Canc Hosp, State Key Lab Mol Oncol,Natl Clin Res Ctr Canc, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16600
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) in patients (pts) with impaired renal function.
    Koshkin, Vadim S.
    Barata, Pedro C.
    Zahoor, Haris
    Rybicki, Lisa A.
    Almassi, Nima
    Redden, Alicia M.
    Fergany, Amr Farouk
    Kaouk, Jihad
    Haber, Georges-Pascal
    Stephenson, Andrew J.
    Martin, Allison
    Allman, Kimberly D.
    Beach, Jennifer
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Rini, Brian I.
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [22] Neoadjuvant cisplatin-based chemotherapy in patients with ureteral obstruction secondary to muscle invasive bladder cancer
    Strother, Marshall
    Kutikov, Alexander
    Lewis, Bianca
    Deng, Mengying
    Handorf, Elizabeth A.
    Epstein, Matthew
    Ghatalia, Pooja
    Greenberg, Richard E.
    Chen, David
    Viterbo, Rosalia
    Anari, Fern
    Smaldone, Marc C.
    Zibelman, Matthew R.
    Uzzo, Robert Guy
    Plimack, Elizabeth R.
    Geynisman, Daniel M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
    Lemberger, Ursula
    Ernhofer, Busra
    Krieger, Sigurd
    Bruchbacher, Andreas
    Oszwald, Andre
    Laukhtina, Ekaterina
    Haitl, Andrea
    Hassler, Melanie R.
    Englinger, Bernhard
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY OPEN SCIENCE, 2025, 71 : 38 - 48
  • [24] TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer
    Qureshi, KN
    Griffiths, TRL
    Robinson, MC
    Marsh, C
    Roberts, JT
    Hall, RR
    Lunec, J
    Neal, DE
    CLINICAL CANCER RESEARCH, 1999, 5 (11) : 3500 - 3507
  • [25] Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer
    Li, Roger
    Nocera, Luigi
    Rose, Kyle M.
    Raggi, Daniele
    Naidu, Shreyas
    Mercinelli, Chiara
    Cigliola, Antonio
    Tateo, Valentina
    Patane, Damiano
    Grass, G. Daniel
    Gilbert, Scott M.
    Sexton, Wade J.
    Bandini, Marco
    Moschini, Marco
    Briganti, Alberto
    Montorsi, Francesco
    Spiess, Philippe E.
    Necchi, Andrea
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 614 - 624
  • [26] Retrospective Analysis of Clinical Outcomes With Neoadjuvant Cisplatin-Based Regimens for Muscle-Invasive Bladder Cancer
    Pal, Sumanta K.
    Ruel, Nora H.
    Wilson, Timothy G.
    Yuh, Bertram E.
    CLINICAL GENITOURINARY CANCER, 2012, 10 (04) : 246 - 250
  • [27] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
  • [28] Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer
    Gong, Jun
    ONCOLOGY-NEW YORK, 2022, 36 (01): : 30 - 31
  • [29] Survivin and ERCC-1 expression as prognostic factor for overall survival in patients with muscle-invasive bladder cancer with and without cisplatin-based chemotherapy
    Kiani, A.
    Kilic, E.
    Jung, K.
    Tervahartiala, M.
    Taimen, P.
    Bostroem, P. J.
    Gleichenhagen, J.
    Johnen, G.
    Pesch, B.
    Bruening, T.
    Blauhut, S.
    Rabien, A.
    Ecke, T. H.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 614 - 614
  • [30] Chemotherapy for Muscle-Invasive Bladder Cancer
    Patrizia Trenta
    Fabio Calabrò
    Linda Cerbone
    Cora N. Sternberg
    Current Treatment Options in Oncology, 2016, 17
12345